Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi

Updated on: January 23,2024 10

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi

Updated on:January 23,2024 10

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma

Updated on: January 29,2024 10

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma

Updated on:January 29,2024 10

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Updated on: January 11,2024 10

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Updated on:January 11,2024 10

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh

Updated on: February 20,2024 14

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh

Updated on:February 20,2024 14

New drug could be advance against glioma brain tumors

by Dennis ThompsonAn experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.The oral drug vorasidenib nearly tripled progress

Updated on: February 18,2024 17

New drug could be advance against glioma brain tumors

by Dennis ThompsonAn experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.The oral drug vorasidenib nearly tripled progress

Updated on:February 18,2024 17

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

by University of SouthamptonMammograms showing a normal breast (left) and a cancerous breast (right). Credit: Wikipedia.A new study led by scientists at the University of Southampton has found th

Updated on: March 01,2024 10

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

by University of SouthamptonMammograms showing a normal breast (left) and a cancerous breast (right). Credit: Wikipedia.A new study led by scientists at the University of Southampton has found th

Updated on:March 01,2024 10

Mass spectrometry can monitor treatment response in multiple myeloma

by Elana GotkineFor patients with newly diagnosed multiple myeloma (MM), mass spectrometry (MS) can monitor treatment response, according to a study published online Jan. 4 inBlood Cancer Journa

Updated on: February 23,2024 13

Mass spectrometry can monitor treatment response in multiple myeloma

by Elana GotkineFor patients with newly diagnosed multiple myeloma (MM), mass spectrometry (MS) can monitor treatment response, according to a study published online Jan. 4 inBlood Cancer Journa

Updated on:February 23,2024 13

Cancer biology graduate student travels 'ROCKy' road toward a cure for post-radiation dry mouth

by University of ArizonaWen Yu "Amy" Wong. Credit: Gaius J. AugustusThe United States is in the midst of a head-and-neck cancer epidemic. Although survival rates are relatively high—aft

Updated on: March 12,2024 11

Cancer biology graduate student travels 'ROCKy' road toward a cure for post-radiation dry mouth

by University of ArizonaWen Yu "Amy" Wong. Credit: Gaius J. AugustusThe United States is in the midst of a head-and-neck cancer epidemic. Although survival rates are relatively high—aft

Updated on:March 12,2024 11

'Never did I imagine that I would have to ration chemotherapy'

by Mary HynesCredit: CC0 Public DomainNationwide shortages of two dozen chemotherapy drugs are leading to rationing and delays in treatment for cancer patients, local and national authorities say.&quo

Updated on: January 10,2024 10

'Never did I imagine that I would have to ration chemotherapy'

by Mary HynesCredit: CC0 Public DomainNationwide shortages of two dozen chemotherapy drugs are leading to rationing and delays in treatment for cancer patients, local and national authorities say.&quo

Updated on:January 10,2024 10

Pilot study of 5-hour molecular test accurately distinguishes malignant and benign breast tumors

by Johns Hopkins University School of MedicineInvestigator Bradley Downs assembling cartridge assay that distinguishes cancer from benign aspirates from mammographically suspicious breast lesions

Updated on: March 14,2024 17

Pilot study of 5-hour molecular test accurately distinguishes malignant and benign breast tumors

by Johns Hopkins University School of MedicineInvestigator Bradley Downs assembling cartridge assay that distinguishes cancer from benign aspirates from mammographically suspicious breast lesions

Updated on:March 14,2024 17

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren

Updated on: January 30,2024 12

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren

Updated on:January 30,2024 12

Appendiceal cancer gets its own preclinical model

byUniversity of California - San DiegoConfocal image of a living tissue slice derived from a patient tumor with metastatic appendiceal cancer (mucinous carcinomatosis peritonei). Immunofluoresce

Updated on: December 28,2023 9

Appendiceal cancer gets its own preclinical model

byUniversity of California - San DiegoConfocal image of a living tissue slice derived from a patient tumor with metastatic appendiceal cancer (mucinous carcinomatosis peritonei). Immunofluoresce

Updated on:December 28,2023 9